Advertisement
Symbiomix Therapeutics LLC
Healthcare
11 October, 2017
Lupin buys US-based Symbiomix Therapeutics for $150 mn
Homegrown drugmaker Lupin Ltd has acquired US-based Symbiomix Therapeutics LLC for a cash consideration of $150 million (Rs 980 crore) ......